Skip to content

Absci Corporation ABSI Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Schrodinger logo
SchrodingerSDGR
$583K
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$0-100%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$2.68M+1,128%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$14.02M+4,735%
ADMA Biologics logo
ADMA BiologicsADMA
$588K+482%
Precigen logo
PrecigenPGEN
$0+100%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+43.6%
Enterprise value$1.57B+73.1%
P/S855.5×+628×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's stock issuance proceeds?
Absci Corporation (ABSI) reported stock issuance proceeds of $7.96M in Q1 2026.
How has Absci Corporation's stock issuance proceeds changed year-over-year?
Absci Corporation's stock issuance proceeds decreased by 80.9% year-over-year, from $41.69M to $7.96M.
What is the long-term trend for Absci Corporation's stock issuance proceeds?
Over 4 years (2021 to 2025), Absci Corporation's stock issuance proceeds has grown at a -15.8% compound annual growth rate (CAGR), from $210.4M to $105.84M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.